Daré Bioscience announces funding award to further the development of Ovaprene Pharmaceutical Investing
Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue Pharmaceutical Investing
Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis Biotech Investing
Naturally Splendid Reports Year End Results for December 31, 2017 CEO Company Update Biotech Investing
Onconova Therapeutics Announces Pricing of $25.0 Million Upsized Underwritten Public Offering Biotech Investing
AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants Medical Device Investing
Lexaria Announces LOI with Hill Street Beverage Co. for Cannabis Infused Alcohol-Free Beer and Wine Biotech Investing
Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006 Pharmaceutical Investing
Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly Biotech Investing
